CD4 and cancer: Furthermore, we found that in early‐relapse HCC, there was an increase in the proportions of CD8+ T cells, NK cells, and malignant tumor cells, while the proportions of CD4+ T cells and myeloid immune cells decreased (Fig. 1E).